...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New Zenith MD&A Posted on SEDAR
1
Sep 29, 2017 01:18PM

"If there is a buyout of Zenith Capital Corp the shares used to calculate our share of the proceeds...."

As I understand it, any buyout would be for Zenith Epigenetics rather than Zenith Capital Corp.  That was the point of the 2 companies.  Zenith Cap owns Zenith Ep and we own shares in Zenith Cap.  So if Zenith Ep gets bought, there's no telling what might filter down to us.

2
Sep 30, 2017 05:33AM
Share
New Message
Please login to post a reply